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We identified a set of transcriptional elements that are conserved and overrepresented within the promoters of human, mouse, and rat GRIAs by
comparing these promoters against a collection of 10,741 gene promoters. Cells regulate functional groups of genes by coordinating the
transcriptional and/or posttranscriptional mRNA levels of interacting genes. As such, it is expected that functional groups of genes share the same
transcriptional features within their promoters. We found 47 genes whose promoters contain the same combination of transcriptional elements that
are overrepresented within the promoters of the GRIA gene family. Coexpressed genes may be transcriptionally coregulated, which in turn
suggests that these genes may play complementary roles within a particular functional context. Using microarray expression data, we found 24 (of
the 47) genes that share not only a similar promoter profile with GRIAs but also a well-correlated gene expression profile and, thus, we believe
these to be coregulated with GRIAs.
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Genome; Computational biologyThe AMPA receptor (GRIA) mediates fast excitatory
synaptic transmission. Its function is essential for diverse
brain activities. For example, AMPA receptors are implicated in
hippocampal long-term potentiation, the processes of learning
and memory acquisition, brain and spinal injury, and seizure as
a result of ischemia, hypoxia, or physical trauma [1,2]. As such,
the study of the mechanisms controlling their expression is of
much interest.
AMPA receptors are heterooligomeric molecules composed
of GRIA1 to GRIA4 subunits (using HGNC nomenclature; also
known as GluR1-4 or GluRA-D). The expression of AMPA⁎ Corresponding author. Fax: +65 67748056.
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doi:10.1016/j.ygeno.2006.11.009receptor subunits is differentially regulated during development
and can be affected by extraneous conditions, for example,
ischemia. A downregulation of GRIA2 gene expression in the
hippocampal CA1 neurons is observed following global
ischemia, leading to an increased Ca2+ influx through AMPA
receptors in response to endogenous glutamate and eventually
to neuronal death [3]. Conversely, increased GRIA2 subunit
levels can be detected in other regions of the hippocampus (e.g.,
dentate gyrus) which are more resistant to ischemic injury [4].
Because AMPA receptors containing the GRIA2 subunit have
low divalent cation permeability, the observed upregulation of
GRIA2 is most probably protective in nature. Furthermore,
changes in AMPA receptor subunit expression can also be
observed following chronic administration of such drugs as
379A. Chong et al. / Genomics 89 (2007) 378–384pyschotropics, pyschostimulants, antidepressants, and antipyscho-
tic medications. Thus, we can clearly see here that AMPA receptor
expression is dynamic.
Initially, we sought key transcription factor binding sites
(TFBSs) within the GRIA promoters that are essential to the
regulation of the expression of GRIA subunits. The identifica-
tion of key transcriptional regulatory elements in the GRIA
promoters has a greater global significance in that it can be
applied in the design of novel gene-targeting constructs. For
example, the identification of a neuronspecific glutamate
receptor promoter element could possibly be used to deliver
future experimental transgene and therapeutic agents to selected
neurons in the brain.
Using a series of biocomputing procedures and statistical
processes, we identified a combination of individual TFBSs and
composite elements that are conserved and overrepresented
within the promoters of the human, mouse, and rat GRIA genes.
A composite element is a set of TFBSs found in combination
and, usually, in close proximity to each other on the promoter,
working synergistically to control the expression of a gene. An
example is the IL-4-responsive element in the SOCS-1
promoter which contains three STAT6 and one Ets consensus
binding sequences [5]. Ets-1 is confirmed to physically interact
with STAT6 and IL-4 responsiveness was either partially or
totally abolished following specific mutations. In the course of
this work, we also identified genes which we believe are
transcriptionally coregulated with GRIAs due to their shared
promoter features with GRIA promoters. These coregulated
genes would be expected to have an expression profile that
correlates well with GRIAs. DNAmicroarrays represent a useful
tool to unravel complex biological networks on a genomewide
scale. The extensive use ofmicroarray technology has resulted in
large repositories of expression data being made available to the
public [6,7]. Furthermore, recent studies have shown that if the
expression of two or more genes is constantly related throughout
many independent microarray datasets, the genes are highly
likely to be functionally related [8,9]. Through the analysis of
publicly available gene expression data, we identified 24 genes,
that share not only a promoter profile but also an expression
profile with GRIAs, which we believe are transcriptionally co-
regulated with GRIAs.
Results and discussion
Promoter profiling the GRIA family
Conserved and overrepresented transcriptional elements
within GRIA promoters. Just as it is believed that there are
gene-specific and tissue-specific transcriptional elements, we
believed that there might be a combination of transcriptional
regulatory elements within the promoters of a gene family that
uniquely controls their expression and that would be conserved
in evolution across the promoters of this gene family in various
species of organisms. To find the family-specific transcriptional
elements of the AMPA receptor genes, we used the approach
developed by Bajic et al. [10] on the promoters of these genes
from the human, rat, and mouse. As there are only four humanGRIA genes, this represents a very small dataset on which to
work. Thus, we also used the promoters of four orthologous
genes from mouse and one orthologous gene from rat. We used
the promoters of these GRIA genes from three species to identify
conserved and overrepresented transcriptional elements, while
using some 10,000-odd promoter sequences as a background for
comparison. This could be viewed as an advanced form of
phylogenetic footprinting. However, we believe that if the gene
family was sufficiently big, this technique could be applied to a
single gene family of a single species.
Computational analysis on a single promoter sequence often
throws up false positive errors; for example, Borges and
Dingledine [11], using MatInspector, found two putative AP-1
sites within the GRIA1 promoter but electrophoretic mobility
shift assays failed to show binding of c-Jun to these sites.
However, our method of feature identification reduces these
errors and provides a higher level of statistical significance
because we are identifying not the individual TFBSs or
composite elements on a single promoter sequence but the
combination of regulatory elements that is characteristic to
several promoter sequences in a gene family.
Based on our analysis, we selected the top-three-ranked
“single,” “pair,” and “triplet” TFBS patterns that were
overrepresented within all nine GRIA promoters that we
studied here (The positions of the “singles,” “pairs,” and
“triplets,” with respect to the transcription start site [TSS], can
be found in the Supplementary Data). We present the top three
overrepresented “single,” “pair,” and “triplet” transcriptional
element of the GRIA promoters in Tables 1a, 1b and 1c.
Various calculations can be used to demonstrate the
statistical significance of the overrepresented transcriptional
elements found in the target promoter set (9 GRIA promoters)
(as contrasted against the background promoter sequence set of
10,741 human promoters). However, one should bear in mind
that biological relevance of a pattern does not invariably mean
that the pattern should be statistically significant. For example,
the initiator element that is required for the initiation of
transcription of many eukaryotic genes is a statistically
insignificant pattern. For this reason, we opted not to select
the patterns in the target promoter group based on any statistical
parameter, except that the patterns have to be present in all
members of the GRIA family that we examined. Nevertheless,
for the sake of completeness, we provide in Tables 1a, 1b, and
1c two sets of statistics that reflect the statistical significance
of these patterns: the overrepresentation index (ORI) and the
p value of the patterns.
This combination of TFBSs and composite elements
characterized the promoters of the GRIA family well. That is
to say, this combination of 3 “singles,” 3 “pairs,” and 3 “triplets”
could be used to distinguish the GRIAs' promoters from among
10,741 gene promoters, although with a small degree of what
we initially thought were “false positive” errors. These “false
positives” are 47 gene promoters from the pool of 10,741
promoters that were found to also have this same combination
of “singles,” “pairs,” and “triplets.” Although this promoter
profile of 3 “singles,” 3 “pairs,” and 3 “triplets” is not entirely
unique to the GRIA promoters, it is still significant as it is
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promoters. This led us to speculate that the reason that these 47
gene promoters share GRIAs' promoter profile is because they
are coregulated/coexpressed with the GRIA genes and play an
important role in GRIA expression or function. These 47 genes
are listed and broadly categorized into 14 functional groups,
ranging from cellular trafficking to transcriptional regulation in
Supplementary Table 1.
Composite elements within GRIA promoters. From among
the TFBSs and composite elements that we identified to be
overrepresented on all nine AMPA receptor gene promoters, we
found that there is prior evidence for the existence of the
composite element pair, MZF1 and GATA (see Table 1b). Yu
and colleagues [12] found that the solitary ERV-9 long terminal
repeat located upstream of the HS5 site in the human beta-
globin in erythroid K562 cells contained DNA motifs that
bound the ubiquitous factor, NF-Y, and MZF1 and GATA-2.
Through protein/protein interactions, NF-Y bound at the
CCAAT motif and recruited MZF1 and GATA-2 and stabilized
their binding to the neighboring GTGGGGA and GATA motifs.
Results suggest that angiotensin (AngII) activates STAT6
and STAT3 and these transcription factors are involved in the
activation of the angiotensinogen (ANG) promoter via their
recognition of the St-domain sequence [13]. In addition, a
STAT3/Lyf-1/MZF1 composite element located in the promoter
region from −238 to −144 of the mouse frizzled-related protein
4 (sFrp4) gene was found to be essential for the promoter
activity of sFrp4 [14]. This suggests that STAT3 and MZF1 may
interact with one another and thus leads us indirectly to believe
that STAT6/MZF1/STAT3 may interact and bind to the
composite element triplet that we identified on the GRIA
promoters (Table 1c).Table 1
Top-three-ranked overrepresented (a) “Singles,” (b) “Pairs,” and (c) “Triplets” found
(a)
TFBS Strand ORI p value
1. CDP CR1 −ve 1.5499 0.02153
2. Sp3 +ve 1.5727 0.01888
3. Bach2 +ve 1.7398 0.00760
(b)
5′→3′
TFBS Strand TFBS Strand
1. GKLF +ve PU.1 +ve
2. MZF1 +ve GATA-2 +ve
3. PU.1 +ve GKLF +ve
The order in which the TFBS appears in each pair is given above from the 5′→3′ d
(c)
5′→3′
TFBS Strand TFBS Strand
1. STAT6 −ve MZF1 +ve
2. ELF-1 +ve STAT1 −ve
3. GKLF +ve PU.1 +ve
The order in which the TFBS appears in each triplet is given above from the 5′→3Cytokine-induced activation of the Fcgamma receptor I
promoter required the DNA binding and the transactivation
functions of both Stat1 and PU.1 [15]. In addition, an analysis of
the human CD40 promoter indicates that the two gamma
activated sequence sites at −521 and −483 and two Ets family
member binding sites located at −553 and −447 are important
for interferon (IFN)-gamma induction of CD40 transcription
[16]. PU.1/Spi-B binds the distal (−553) while PU.1 binds the
proximal (−447) Ets sites. How these transcription factors
cooperate to switch on CD40 promoter activity is unclear but
their close proximity might suggest a direct interaction of
STAT1/PU.1/Spi-B. Further evidence of STAT1/PU.1 coopera-
tivity can also be seen in IFN-gamma's induction of transcription
ofmacrophage fgl2 gene [17]. Incidentally, it is believed that IFN-
gamma treatment of spinal dorsal horn neurons causes a reduced
expression of GluR1 [18]. It should also be noted that IFN-
gamma can increase the expression of GKLF [19]. We therefore
postulate that the GKLF/PU.1/STAT1 composite element that we
identified (Table 1c) may play a role in the IFN-gamma-mediated
decrease of GluR1 expression.
Analysis of genes that are coexpressed with GRIAs
To support our claim that the above 47 genes are coregulated/
coexpressed with GRIAs, we used available expression data
repositories and tools to find evidence to show that these genes
and GRIAs have a statistically correlated coexpression pattern.
We used publicly available resources to find genes that show a
pattern of expression similar to that of the GRIA family of genes.
Gene sorter. The first resource is provided by the UCSC
Genome Browser called Gene Sorter [20]. Mining through the






TFBS Strand ORI p value
STAT3 −ve 4.3538 2.1958e-006
Pax-4 −ve 4.4384 1.8460e-006
STAT1 −ve 5.5722 2.3734e-007
′ direction.
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the 47 genes that share GRIAs' promoter profile, we found that
16 are among this list of 4793 closely coexpressed genes
identified by Gene Sorter (Table 2). In other words, 16 genes
were identified to share not only a promoter profile but also a
similar expression profile.
Gene expression omnibus (GEO). Next, we used National
Center for Biotechnology Information's (NCBI) gene expres-
sion omnibus to perform a similar search for genes that have an
expression profile correlated to that of the GRIAs [7]. Here, we
found 7354 such genes (termed “profile neighbors” by GEO)
expressed in brain, of which 10 are among the list of 47 genes
that share GRIAs' promoter profile (Table 2). In other words, 10
genes were found to be closely coexpressed with GRIAs while
also sharing GRIA's promoter profile. However, of these 10
genes, 6 were the same as those identified by Gene Sorter.
CLEO Database (based on data from the Stanford Micro-
array Database). With data provided by Ferdinando DiCunto
from the CLEO database [21], we analysed the top 1% of genes
with a coexpression pattern statistically correlated to that of the
GRIAs from the human and mouse gene expression data of the
Stanford Microarray Database [6]. Here, we found that of the 47
genes that share GRIAs' promoter profile, 10 are among the top
1%—6 genes (of 2202 human genes that were found closely
coexpressed with GRIA) from the human gene expression data
and 4 genes (of 1287 mouse genes that were found closely
coexpressed with GRIA) from the mouse gene expression data
(Table 2). In other words, 10 genes were found to be closely
coexpressed with GRIAs while also sharing GRIA's promoterTable 2
Genes that are closely coexpressed with GRIAs as determined by analyses of





















1 576 BAI2 ✓ ✓ ✓
2 911 CD1C ✓
3 2323 (14256) FLT3LG ✓
4 3603 IL16 ✓ ✓
5 4793 NFKBIB ✓
6 5279 PIGC ✓ ✓
7 5653 (19144) KLK6 ✓ ✓
8 5865 RAB3B ✓
9 8674 VAMP4 ✓
10 9746 CLSTN3 ✓ ✓
11 11131 CAPN11 ✓
12 11170 FAM107A ✓ ✓ ✓
13 23276 KLHL18 ✓ ✓
14 25852 ARMC8 ✓
15 27120 (50722) DKKL1 ✓ ✓
16 54093 SETD4 ✓
17 54897 CASZ1 ✓
18 55244 (67473) FLJ10847 ✓
19 55859 BEX1 ✓ ✓
20 56999 ADAMTS9 ✓
21 64225 ARL6IP2 ✓
22 64577 ALDH8A1 ✓
23 79980 DSN1 ✓ ✓
24 80227 WDR71 ✓profile. However, of these 10, 6 were the same as those
identified by either Gene Sorter and/or GEO.
There are approximately 20,000 confirmed protein-coding
human genes (The International Human Genome Sequencing
Consortium confirms the existence of 19,599 protein-coding
genes). Examining the data for the human gene population, we
calculated the p value for enrichment to be 4.046736e−002 (after
conservative correction for multiplicity testing done with the
Bonferroni method) for genes that are closely coexpressed with
GRIAs while also sharing a similar promoter profile (See
Supplementary Information for details). Furthermore, support
for the coexpression with GRIAs is confirmed by two or more
of the above-mentioned analyses for 10 genes (that is, our
analyses of the human and mouse gene expression data, NCBI's
GEO, and/or the human Gene Sorter program) (Table 2).
For the UCSC Gene Sorter results, the similarity in
expression of two genes is calculated by a weighted sum of
differences in log expression ratio values, whereas, for our
analysis of the data from the Stanford Microarray Database and
for GEO Profiles' precalculated profile neighbors, a calculation
of the Pearson's correlation coefficient was made to acertain the
closeness in expression of two genes. If one were to use the
UCSC results as a point of reference, then by two different
methods of expression profiling we can find at least eight
different genes that are not only confirmed to be coexpressed
with GRIA but also share a similar promoter profile. These eight
genes (BAI2, IL16, KLK6, CLSTN3, FAM107A, KLHL18,
BEX1, DSN1) therefore represent very strong candidates for
further laboratory studies.
Coexpression data support hypothesis of coregulated genes
By coregulation, we mean that the transcriptional regulation
of a particular gene is closely linked to the transcription of GRIA
genes due to their shared promoter characteristics. Coregulated
genes are believed to be functionally related and play a
significant role in aiding the function and expression of their
partner. While coregulation of two genes may result in the
coexpression of these two genes in the same tissue, coexpression
of two genes in the same tissue does not necessarily mean that
they are transcriptionally coregulated since their coexpression
may be coincidental. However, we should not also expect two
transcriptionally coregulated genes to always be coexpressed
since their transcriptional coregulation may take place only
under the right physiological conditions; transcription, after all,
is affected by various factors, such as, tissue specificity. Recent
studies have shown that if the expression of two or more genes is
constantly related throughout many independent microarray
datasets, the genes display a significant degree of functional
similarity [8,9]. In this context, it is interesting to note that 10
genes were repeatedly shown to be coexpressed with GRIAs by
our analysis of the human and mouse data from the Stanford
Microarray Database and by the Gene Sorter tool and/or NCBI's
GEO. Particularly interesting is the close coexpression of KLK6
with GRIA that was found in human (by Gene Sorter) and in
mouse (Stanford Microarray Database) which strongly suggests
a functional relationship between these two genes. Phylogenetic
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identifying functionally relevant coexpression links between
genes [22]. Conservation implies that the coexpression of the
gene pairs confers a selective advantage and, therefore, these
genes are most likely functionally related.
Here, we have coupled promoter profiling with the analysis
of coexpression data from various microarray experiments.
Together, they lend support to one another in suggesting that at
least 24 genes that we have identified are functionally
coregulated (see Table 2) since the chance of 2 genes sharing
similar promoter characteristics and expression patterns goes
beyond mere coincidence (please refer to the online Supple-
mentary Information for a calculation of the p value for
finding genes that both have a highly correlated coexpression
with the GRIAs and share the same set of promoter elements
as those that we selected). Among these 24 genes which we
believe are coregulated with GRIAs are Rab3B and calsynte-
nin 3 (CLSTN3).
Rab3B belongs to the Rab3 family of small GTP-binding
proteins which include Rab3A, Rab3C, and Rab3D that function
in regulated exocytosis in various secretory cells [23].
Recruitment of AMPA receptors to the synapse is driven by
calmodulin-dependent protein kinase II (CAMKII) [24]. Inci-
dentally, Rab3B binds and interacts with Ca2+-calmodulin
(CaM) in a calcium-dependent manner and was shown to be
involved in Ca2+-dependent exocytosis in rat anterior pituitary
cells [25,26]. Immunocytochemistry studies confirm the pres-
ence of GRIA1- and GRIA2/3-positive cells in the anterior and
intermediate lobes of the pituitary [27]. Also, it is thought that
the delivery of AMPA receptors to the synaptic membrane
occurs through an exocytic pathway [28]. The localization of
Rab3B on synaptic vesicles and its demonstrated interactionwith
Ca2+-CaM in exocytosis, coupled with its matching expression
profile with GRIAs' in the brain, provide a strong indication that
Rab3B might be enlisted to help in the surface expression of
AMPA glutamate receptors.
CLSTN3 belongs to a recently discovered family of novel
postsynaptic membrane proteins and was identified as a target
protein of extracellular proteases [29]. Synaptic plasticity is
accompanied by structural changes in and around the synapse
and these structural reorganizations are due to the action of
extracellular proteases, such as tissue plasminogen activator and
neuropsin [30–32]. The exact function of calsyntenins is
unknown; however, immunoelectron microscopy reveals that
all three calsyntenins are located in the postsynaptic membrane
of asymmetrical (excitatory) synapses [29]. There is ample
evidence showing that excitatory AMPA glutamate receptors
are also found on postsynaptic dendritic spines of asymmetrical
synapses [33–36]. In addition, Hintsch and co-workers [29]
demonstrated that several clearly discernible populations of
glutamatergic neurons, such as those in neocortical layer 5 and
the hippocampal CA1-CA3 regions, expressed high levels of
CLSTN3. Because CLSTN3 is a target of extracellular proteases
that play a central role in synaptic plasticity, we believe that
CLSTN3 is coexpressed/coregulated in neurons undergoing
AMPA-receptor-mediated synaptic plasticity to aid in structural
reorganization of the synapse.One pertinent question that arises is what if microarray
expression data do not show a coexpression of a particular gene
(say, Gene X) with GRIA? Can we definitively say that this is a
false positive prediction? The answer is, of course, no. The
circumstances under which Gene X would be coregulated with
GRIA may not be present during the microarray experiment (for
example, perhaps the cells need to be treated with tumor
necrosis factor-alpha for us to see a coregulated expression of
Gene X and GRIA).
In further support of our contention that the 47 genes are
coregulated with GRIAs, a search for the expression profiles of
all 47 genes in UCSC's Gene Sorter and GEO confirms that all
47 genes are expressed in the brain (fetal and/or adult) to
varying degrees. This is important since AMPA receptors are
found predominantly in the nervous system.
Conclusion
Our initial aim was to find a family-specific set of transcrip-
tional elements that were significantly conserved across the
GRIA promoters. We found, instead, a set of transcriptional
elements that was shared by GRIAs and their functionally
related coregulated genes. In other words, we found a function-
specific set of transcriptional elements. Promoter profiling helped
us identify unique promoter features common among func-
tionally related genes which control their transcription and
thus, in this process, we were able to identify what we believed
are genes coregulated with GRIAs. Experimental validation of
their coregulated expression was obtained from the wealth of
freely available microarray expression data. Recent studies
have shown that two genes are functionally related if their
expression is consistently related in various independent
microarray datasets [8,9]. Even so, as we can see, for example
from GEO, an analysis of various expression datasets can yield
thousands of so-called profile neighbors. Therefore, on their
own, neither of these two methods can definitively identify
functional groups of coregulated genes, however, by combin-
ing these two methods (promoter and expression profiling), we
provide strong justification to suggest that at least 24 novel
genes are functionally related to and transcriptionally coregu-
lated with the GRIA family. This conclusion is based on three
characteristics: a common promoter profile, a common ex-
pression profile, and high statistical significance. More work
will need to be done in the laboratory to fully elucidate the role
of these genes in AMPA receptor physiology; however, the
results that we present here give a solid foundation on which to
base future investigations/search for interacting partners of
AMPA receptors.
A different approach to take would have been to reverse the
process followed here, that is to first identify a small group of
genes tightly coexpressed with GRIA and then proceed with
promoter profiling. However, the argument against such an
approach is that, by first clustering genes based on expression
profiles, you obtain clusters that contain not only one group of
coregulated genes but generally many different groups of
coregulated genes placed in the same coexpression cluster.
Because of this, such an approach produces clusters that
383A. Chong et al. / Genomics 89 (2007) 378–384dominantly contain a group of genes coregulated in the same
manner only in exceptional cases.
There are a number of published methods that relate to
combined analysis of motifs in promoters and their links to
expression [37–42]. However, none of these methods allows us
to use efficiently the whole set of TRANSFAC matrix models
for the human promoter set that we had (10741) and to generate
automatically combinations of patterns for “pairs” and for
“triplet” as our in-house developed tool did. We, however, do
not exclude the possibility that results similar to those presented




Promoter sequences (10,741) of human genes covering the region −1500 to
+1000 (with respect to the transcription start site) were collected by the FIE2
program [43]. The release of the human genomic sequences at the time of
collection was NCBI Build 31. The extraction of the human GRIA promoters
was done similarly. For the mouse GRIA promoter sequences, the alignments of
the individual mouse GRIA genes against the then available mouse genomic
sequences from the Mouse Genome Sequencing Consortium (MGSCv3) were
obtained from NCBI's LocusLink [44]. The 5′ ends of the extracted mouse
GRIA sequences were passed through the Dragon Promoter Finder [45] to
predict the TSS for these genes. At the start of this study, work on the rat
genomic sequence was at its threshold and so only the rat GRIA1 promoter
sequence (AF302117) [11] was used. Five TSSs were previously identified for
the rat GRIA1 gene. For this study, we chose the 5′-most TSS as a point of
reference.
Comparison of target promoters against background promoters
GRIA promoters (target promoters) were compared with the 10,741
promoters (background promoters) collected by FIE2 to determine the
overrepresented transcriptional elements within GRIA promoters. To do this,
we first mapped all TFBSs from TRANSFAC Professional database ver. 6.2 [46]
to all promoter sequences. This mapping was carried out using the MATCH
program [47] with the “minsum” setting. This parameter setting allows for the
minimized sum of false positive and false negative predictions of TFBSs. Once
that was done, we compared densities of individual TFBSs in the target and
background promoters and calculated the overrepresentation for each TFBS, that
is determining how much more dense a particular TFBS is in the GRIA
promoters with respect to the background promoters following the procedure
that we previously described [10]. These individual TFBSs were termed
“singles.” Similarly, we repeated the analysis for all combinations of paired
TFBSs where the two TFBSs were no more than 50 nt apart (which we termed
“pairs”). The same analysis was also carried out for combinations of three
TFBSs, with maximal mutual distance of neighboring TFBSs not greater than
50 nt (which we termed “triplets”).
Identification of closely coexpressed genes
An analysis of human and mouse gene expression data from the Stanford
Microarray Database [6] was performed to obtain the top 1% of genes which are
closely coexpressed with GRIAs. This was done by the method previously
described by Pellegrino et al. [21]. We also performed a search for genes with
similar expression patterns using the Human Gene Sorter tool [20]. The Gene
Sorter calculates and displays genes by their similarity in expression to a
selected gene. The similarity is calculated as a weighted sum of differences in
log expression ratio values using the expression data from such sources as the
GNFGene Expression Atlas 2 [48]. In addition, we used the NCBI GEO “profile
neighbor” function to obtain a list of genes that are closely related in expression
to the GRIAs, based on data deposited in GEO [7].P value calculation
We used the right-sided Fisher's exact test based on hypergeometric
distribution. Where the p values are corrected by the Bonferroni method for
multiplicity testing, this is explicitly indicated.Acknowledgments
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